US Stock MarketDetailed Quotes

UCBJF UCB S.A.

Watchlist
  • 194.850
  • 0.0000.00%
15min DelayClose Jan 7 16:00 ET
36.97BMarket Cap154.89P/E (TTM)

About UCB S.A. Company

UCB SA engages in the research and development of biopharmaceuticals products. It offers medicinal products such as briviact, keppra, vimpat, neupro, cimzia, nootropil, xyrem, xyzal, and zyrtec. The company was founded by Emmanuel Janssen on January 18, 1928 and is headquartered in Brussels, Belgium.

Company Profile

SymbolUCBJF
Company NameUCB S.A.
Founded1925
CEOMr. Jean-Christophe Tellier
MarketPink Market
Employees9083
Fiscal Year Ends12-31
AddressAllée de la Recherche, 60
CityBrussels
ProvinceBrussels Region
CountryBelgium
Zip Code1070
Phone32-2-559-99-99
Websitehttp://www.ucb.com

Company Executives

  • Name
  • Position
  • Salary
  • Jean-Christophe Tellier
  • Director and Chief Executive Officer
  • --
  • Fiona du Monceau
  • Vice Chairman of the Board
  • --
  • Jonathan M. Peacock
  • Chairman of the Board
  • --
  • Cedric van Rijckevorsel
  • Director
  • --
  • Albrecht De Graeve
  • Director
  • --
  • Cyril Janssen
  • Director
  • --
  • Charles-Antoine Janssen
  • Director
  • --
  • Maelys Castella
  • Independent Director
  • --
  • Ulf Wiinberg
  • Independent Director
  • --
  • Dr. Jan Berger
  • Independent Director
  • --
  • Susan Gasser
  • Independent Director
  • --
  • Pierre Gurdjian
  • Independent Director
  • --
  • Kay Davies
  • Independent Director
  • --
Heat List
US
Overall
Symbol
Price
% Chg

No Data